From AI-driven R&D to digital supply chains and next-generation biomanufacturing, this collection covers the full breadth of where pharma and biotech innovation stands in mid-2026.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Compelling solutions through strategic partnerships
